Table IV.
CTC-PV/CTM-PV counts of 4 patients with lung cancer andpostoperative recurrence.
| Patient no. | Histology | Tumor size (cm) | Stage | CTC-PV | CTM-PV | DFS (months) | OS (months) |
|---|---|---|---|---|---|---|---|
| 1 | Squamous | 7.0 | pT2bN0M0 | 9 | 0 | 7 | 10 |
| 2 | Squamous | 2.5 | ypT2aN0M0 | 23 | 0 | 3 | 4 |
| 3 | Adenocarcinoma | 5.5 | pT2bN2M0 | 101 | 6 | 2 | 6 |
| 4a | Adenocarcinoma | 9.0 | pT3N0M0 | 3,500 | 24 | 13 | Alive |
a
The computed tomographyimage of this patient is shown in Fig.3A. CTC, circulating tumor cell; CTM, circulating tumor microemboli; PV, pulmonary vein; DFS, disease-free survival; OS, overall survival.